Search Results for: hepatitis C virus

February 20, 2015February 20, 2015

Nearly a Fifth of Prisoners Have Infectious and Chronic Medical Conditions, Including Hepatitis B and C

News

Almost a fifth of US state and federal prisoners currently suffer from an infectious disease, including hepatitis B, hepatitis C, tuberculosis or other sexually transmitted disease (STD); and about 40% of ... Read more

February 13, 2015February 13, 2015

Study Reveals Hepatitis C Lacks Equal Attention Than HIV/AIDS or Ebola Yet is More Prevalent

Hepatitis B, Hepatitis C, News

A new study on Hepatitis C virus in West Africa entitled “High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways” was ... Read more

February 11, 2015February 13, 2015

AbbVie Reports Phase 3 Data on Ombitasvir-Paritaprevir-Ritonavir Therapy for Hepatitis C in Japan

Hepatitis C, News

AbbVie announced findings from a Phase 3 clinical trial (GIFT-I (M13-004)) for its new oral, ribavirin (RBV)-free antiviral treatment with a fixed-dose combination of paritaprevir/ritonavir (150/100 mg) with ombitasvir (25 mg), ... Read more

February 4, 2015February 5, 2015

Tekmira Begins Phase I Clinical Trial Of TKM-HBV For Hepatitis B

News

Tekmira Pharmaceuticals Corporation, a leading company in the development of RNA interference (RNAi) therapeutics, recently announced they have successfully dosed the first subject in a Phase I clinical trial of TKM-HBV – a therapeutic drug ... Read more

January 30, 2015January 30, 2015

Widespread Screening For Hepatitis C May Cause More Harm Than Benefits

News

Various organizations have suggested a boost in screenings for hepatitis C infection. However, experts reported caution, as published in the The BMJ in an article titled “Is widespread screening for hepatitis C justified?“ that this demand is ... Read more

January 29, 2015January 29, 2015

Mylan Launches Generic Epivir-HBV® by GSK for Hepatitis B

News

Mylan Inc. announced the United States launch of their generic formulation of GlaxoSmithKline’s Epivir-HBV® Lamivudine Tablets, 100 mg. The company received the FDA’s final approval for its Abbreviated New Drug Application (ANDA), appropriated for ... Read more

January 28, 2015January 27, 2015

Hepatitis B Vaccine May be Linked to Chronic Fatigue Syndrome and Fibromyalgia According to Study

Hepatitis B, News

A new study on the association between hepatitis B vaccination (HBVv), fibromyalgia and chronic fatigue entitled “Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle ... Read more

January 28, 2015January 28, 2015

Hepatitis C Treatment VIEKIRAX® + EXVIERA® Now EMA-Approved

News

The European Commission has granted marketing authorizations for AbbVie’s all-oral, interferon-free, short-course treatment with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets). This treatment was recently approved with or without ribavirin (RBV) for patients suffering ... Read more

January 26, 2015January 26, 2015

Gilead’s Hepatitis C Treatment Sofosbuvir Rejected in India

News

Gilead Sciences, Inc.‘s application to commercialize novel hepatitis C treatment sofosbuvir in India has been rejected by the country’s patent office, as reported by Reuters. The refusal may open a new ... Read more

January 21, 2015January 21, 2015

Benitec Biopharma Advances Hepatitis C Clinical Trial

News

Benitec Biopharma Limited announced that it has dosed the third patient in its Phase I/IIa clinical trial with TT-034 for hepatitis C, at the Duke Clinical Research Unit (USA). This marks an ... Read more